Search filters
Filters
Clear AllPhase
-
183
-
156
-
2
-
194
-
1
-
152
-
17
-
402
Age
-
1246
-
593
Gender
-
29
-
49
-
3
-
1172
Virtual Trials
-
1247
-
6
New Trials
-
4
-
1249
Found 1253 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Assessing Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis
This is an extension study for subjects over the age of 18, diagnosed with moderate-to-severe atopic dermatitis and enrolled in our main study IRB # 845325. This research study is being conducted to test the safety of lebrikizumab and potential side effects. Procedures include Physical exams, Medical History, blood and …
An Open-Label Study For Continued Treatment Access For Participants From The B9991032 Avelumab Study
The purpose of the continuation sub-study is to provide continued treatment access for participants from the B9991032 Parent Study who are deriving benefit from study treatment as judged by the investigator.
ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery
The purpose of this study is to assess the safety of ALM-488, and to learn how well it shows nerve tissue in the body.
Understanding the long-term impact of COVID on children and families
Purpose of this study is to understand why some people who got COVID-19 are still sick many months after being infected, and how this affects the body. This is sometimes called “Long COVID” or “PASC”, which stands for post-acute sequelae of SARS-CoV-2 infection. Children who have and have not had …
Evaluating the Effect of Sage-718 on Cognitive Function in Participants with Huntington’s Disease
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
Evaluating the Long-term Safety of Apraglutide in Short Bowel Syndrome
The purpose of this extension trial is to find out how safe and how well the trial drug, apraglutide, is tolerated when you are treated for up to 104 weeks and to see if there are any changes in how much parenteral support (PS) you need.
UPCC 15820: A Phase 3 Randomized Placebo-controlled Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
The purpose of this study is to see if niraparib added to a standard treatment (abiraterone acetate and prednisone) will work better than abiraterone acetate and prednisone alone in treating men with metastatic prostate cancer with specific genetic changes. Eligible subjects will be men with metastatic prostate cancer.
A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas
This study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real time detection and visualization of meningiomas during tumor resection surgery. Potential patients who sign informed consent will be screened for eligibility before receiving an oral solution of Gleolan 3 hours prior to …
Evaluating Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis
The purpose of this study is to evaluate how well the study drug (Navitoclax) works in combination with ruxolitinib when compared to best available therapy in subjects with Relapsed/Refractory Myelofibrosis.
Study of Drug Serabelisib in Combination with an Insulin Suppressing Diet in Subjects with Cancer
The main purpose of this research is to try and find a better way to treat cancer. Specifically, this research will study how participants tolerate and might benefit from combining a special diet that is low in carbohydrates and high in fat with a drug intended to treat cancer (called …
Please choose between Voice or SMS based delivery of verification code
or